Maile v. Kijakazi

CourtDistrict Court, D. Minnesota
DecidedSeptember 28, 2022
Docket0:21-cv-00199
StatusUnknown

This text of Maile v. Kijakazi (Maile v. Kijakazi) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Maile v. Kijakazi, (mnd 2022).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

Troy L. M., Case No. 21-cv-199 (TNL)

Plaintiff,

v. ORDER

Kilolo Kijakazi, Acting Commissioner of Social Security,1

Defendant.

Clifford Michael Farrell, Manring & Farrell, P.O. Box 15037, 167 North High Street, Columbus, OH 43215-0037; and Edward C. Olson, Disability Attorneys of Minnesota, 331 Second Avenue South, Suite 890, Minneapolis, MN 55401 (for Plaintiff); and

Michael Moss, Special Assistant United States Attorney, Social Security Administration, 1301 Young Street, Suite 350, Mailroom 104, Dallas, TX 75202 (for Defendant).

I. INTRODUCTION Plaintiff Troy L. M. brings the present case, contesting Defendant Commissioner of Social Security’s denial of his applications for disability insurance benefits (“DIB”) under Title II of the Social Security Act, 42 U.S.C. § 401 et seq., and supplemental security income (“SSI”) under Title XVI of the same, 42 U.S.C. § 1381 et seq. The parties have consented to a final judgment from the undersigned United States Magistrate Judge in accordance with 28 U.S.C. § 636(c), Fed. R. Civ. P. 73, and D. Minn. LR 72.1(c).

1 The Court has substituted Acting Commissioner Kilolo Kijakazi for Andrew Saul. A public officer’s “successor is automatically substituted as a party” and “[l]ater proceedings should be in the substituted party’s name.” Fed. R. Civ. P. 25(d). This matter is before the Court on the parties’ cross motions for summary judgment. ECF Nos. 20, 22, and Plaintiff’s Notice of Supplemental Authority and Motion to Remand,

ECF No. 26. Being duly advised of all the files, records, and proceedings herein, IT IS HEREBY ORDERED that Plaintiff’s Motion for Summary Judgment, ECF No. 20, is GRANTED IN PART and DENIED IN PART; the Commissioner’s Motion for Summary Judgment, ECF No. 22, is GRANTED IN PART and DENIED IN PART; and Plaintiff’s Notice of Supplemental Authority and Motion to Remand, ECF No. 26, is GRANTED IN PART as to the relief sought and is otherwise DENIED.

II. PROCEDURAL HISTORY Plaintiff applied for DIB and SSI asserting that he has been disabled since September 2017 due to, among other impairments, depression and anxiety.2 Tr. 25, 74, 91, 92, 112, 129, 130. Plaintiff’s applications were denied initially and again upon reconsideration. Tr. 25, 89, 106, 108, 110, 127, 144, 146, 148.

Plaintiff appealed the reconsideration of his DIB and SSI determinations by requesting a hearing before an administrative law judge (“ALJ”). Tr. 25, 171-72. The ALJ held a hearing in March 2020, and issued an unfavorable decision. Tr. 25-37, 75-73. Thereafter, Plaintiff requested review from the Appeals Council, which was denied. Tr. 1- 4.

Plaintiff then filed the instant action, challenging the ALJ’s decision. Compl., ECF No. 1. The parties have filed cross motions for summary judgment. ECF Nos. 20, 22.

2 While Plaintiff also claimed disability on the basis of physical impairments (“[b]ack [p]roblems,” a “[t]ear in [d]isc,” “[d]egenerative [d]isk [d]isease,” and “[m]igraines”), Tr. 75, 92, 113, 130, the opinion evidence and prior administrative medical findings at issue concern Plaintiff’s mental impairments. Subsequent to these motions being fully briefed, Plaintiff submitted a combined Notice of Supplemental Authority and Motion to Remand, ECF No. 26. The Court directed the

Commissioner to respond to the motion to remand and provided Plaintiff an opportunity to file a reply. ECF No. 27; see generally ECF Nos. 28, 29. This matter is now ready for a determination on the papers. III. RELEVANT MEDICAL RECORDS Plaintiff has a history of major depressive disorder and anxiety disorder. See, e.g., Tr. 595, 619, 463. These conditions were being treated by Timothy Rasmussen, MD. Tr.

595, 619, 463. As of September 2016, Plaintiff was taking Wellbutrin XL,3 Xanax,4 Remeron,5 and trazodone.6 Tr. 595. At this time, Dr. Rasmussen described Plaintiff’s depression as being “in partial remission.” Tr. 595. A. 2017 In early February 2017, Plaintiff saw Dr. Rasmussen for a medication management

appointment. Tr. 597. Dr. Rasmussen noted that Plaintiff was “doing fairly well,” had a “stable mood,” and “love[d] his job.” Tr. 597; see Tr. 619 (last job was working in housekeeping at a nursing home). Plaintiff’s depression remained in partial remission and Dr. Rasmussen continued Plaintiff’s medications as prescribed. Tr. 597.

3 Wellbutrin XL is a brand name for bupropion, a medication used to treat depression. Bupropion, MedlinePlus, Nat’l Lib. of Med., https://medlineplus.gov/druginfo/meds/a695033.html (last accessed Sept. 16, 2022). 4 Xanax is a brand name for alprazolam, a medication used to treat anxiety disorders. Alprazolam, MedlinePlus, Nat’l Lib. of Med., https://medlineplus.gov/druginfo/meds/a684001.html (last accessed Sept. 16, 2022). 5 Remeron is a brand name for mirtazapine, a medication used to treat depression. Mirtazapine, MedlinePlus, Nat’l Lib. of Med., https://medlineplus.gov/druginfo/meds/a697009.html (last accessed Sept. 16, 2022). 6 “Trazodone is used to treat depression.” Trazodone, MedlinePlus, Nat’l Lib. of Med., https://medlineplus.gov/ druginfo/meds/a681038html (last accessed Sept. 16, 2022). Approximately three months later, towards the end of May, Plaintiff reported that he “has been a little more depressed and extremely anxious.” Tr. 599. Plaintiff was

worried about the health of his parents and “[w]hat will happen to him after they pass away.” Tr. 599. Plaintiff was also stressed as he had not received a performance review “in a year.” Tr. 599. Plaintiff reported feeling “very tired” in the morning and “sleepy during the day.” Tr. 599. Dr. Rasmussen increased Plaintiff’s Remeron prescription “to help with depression” and reduced his trazodone prescription. Tr. 599. At his next medication management appointment in the middle of August, Plaintiff

reported feeling “a little down and anxious.” Tr. 601. Plaintiff reported “[h]is mother is driving him up the wall because she is so anxious at times.” Tr. 601. When Dr. Rasmussen saw Plaintiff again approximately two months later, he noted that Plaintiff was prescribed Cymbalta7 by his primary care provider, but it made Plaintiff feel tired and “really didn’t help his pain.” Tr. 603. Dr. Rasmussen noted that ideally

Plaintiff would be on a higher dose, but because Plaintiff “felt so tired on it,” Dr. Rasmussen thought “it would have been counterproductive to increase it.” Tr. 603. Dr. Rasmussen recommended a trial of Fetzima,8 which “has some similarities to Cymbalta and how it works and it’s more energizing.” Tr. 603. Dr. Rasmussen noted he would obtain some samples for Plaintiff. Tr. 603.

7 Cymbalta is a brand name for duloxetine, a medication used to treat depression and anxiety. Duloxetine, MedlinePlus, Nat’l Lib. of Med., https://medlineplus.gov/druginfo/meds/a604030html (last accessed Sept. 16, 2022). 8 Fetzima is a brand name for levomilnacipran, a medication used to treat depression. Levomilnacipran, MedlinePlus, Nat’l Lib. of Med., https://medlineplus.gov/druginfo/meds/a613048html (last accessed Sept. 16, 2022). Plaintiff returned in early November and Dr. Rasmussen noted that Plaintiff had not picked up the Fetzima samples he had obtained for him. Tr. 605. Plaintiff was still

interested in trying the medication. Tr. 605.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Halverson v. Astrue
600 F.3d 922 (Eighth Circuit, 2010)
Martise v. Astrue
641 F.3d 909 (Eighth Circuit, 2011)
Boettcher v. Astrue
652 F.3d 860 (Eighth Circuit, 2011)
David Perks v. Michael J. Astrue
687 F.3d 1086 (Eighth Circuit, 2012)
Cox v. Astrue
495 F.3d 614 (Eighth Circuit, 2007)
Moore v. Astrue
572 F.3d 520 (Eighth Circuit, 2009)
Flaherty v. Halter
182 F. Supp. 2d 824 (D. Minnesota, 2001)
Travis Chaney v. Carolyn W. Colvin
812 F.3d 672 (Eighth Circuit, 2016)
Bryce Mabry v. Carolyn W. Colvin
815 F.3d 386 (Eighth Circuit, 2016)
Marcus Hensley v. Carolyn W. Colvin
829 F.3d 926 (Eighth Circuit, 2016)
Willie Boyd, Jr. v. Carolyn W. Colvin
831 F.3d 1015 (Eighth Circuit, 2016)
Stephen Chismarich v. Nancy A. Berryhill
888 F.3d 978 (Eighth Circuit, 2018)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)
Robert Paul Dols v. Andrew M. Saul
931 F.3d 741 (Eighth Circuit, 2019)
Veronica Grindley v. Kilolo Kijakazi
9 F.4th 622 (Eighth Circuit, 2021)
Sara Schmitt v. Kilolo Kijakazi, Acting Commis
27 F.4th 1353 (Eighth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Maile v. Kijakazi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/maile-v-kijakazi-mnd-2022.